Have a feature idea you'd love to see implemented?
Let us know!
OM Outset Medical Inc
Price (delayed)
$1.13
Market cap
$59.37M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.75
Enterprise value
$224.84M
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to
Highlights
OM's gross margin has surged by 54% year-on-year and by 10% since the previous quarter
OM's gross profit is up by 34% year-on-year and by 8% since the previous quarter
OM's quick ratio is up by 15% year-on-year but it is down by 6% since the previous quarter
OM's debt has soared by 96% YoY
The equity has plunged by 69% YoY and by 30% from the previous quarter
Key stats
What are the main financial stats of OM
Market
Valuations
Earnings
Shares outstanding
52.54M
Market cap
$59.37M
Enterprise value
$224.84M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.23
Price to sales (P/S)
0.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.96
Revenue
$114.73M
Gross profit
$35.53M
Net income
-$140.94M
EBIT
-$118.87M
EBITDA
-$111.69M
Free cash flow
-$126.18M
Per share
Balance sheet
Liquidity
EPS
-$2.75
EPS diluted
-$2.75
Free cash flow per share
-$2.5
Book value per share
$0.92
Revenue per share
$2.27
TBVPS
$5.8
Total assets
$292.89M
Total liabilities
$245.07M
Debt
$202.08M
Equity
$47.82M
Working capital
$232.84M
Debt to equity
4.23
Current ratio
6.49
Quick ratio
5.03
Net debt/EBITDA
-1.48
Margins
Efficiency
Dividend
EBITDA margin
-97.3%
Gross margin
31%
Net margin
-122.8%
Operating margin
-112.3%
Return on assets
-44.5%
Return on equity
-169.5%
Return on invested capital
-29.1%
Return on capital employed
-47.5%
Return on sales
-103.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OM stock price
How has the Outset Medical stock price performed over time
Intraday
-4.24%
1 week
11.88%
1 month
34.91%
1 year
-79.23%
YTD
-79.11%
QTD
66.91%
Financial performance
How have Outset Medical's revenue and profit performed over time
Revenue
$114.73M
Gross profit
$35.53M
Operating income
-$128.87M
Net income
-$140.94M
Gross margin
31%
Net margin
-122.8%
OM's gross margin has surged by 54% year-on-year and by 10% since the previous quarter
OM's gross profit is up by 34% year-on-year and by 8% since the previous quarter
Outset Medical's operating income has increased by 25% YoY and by 14% QoQ
The net income is up by 20% year-on-year and by 11% since the previous quarter
Growth
What is Outset Medical's growth rate over time
Valuation
What is Outset Medical stock price valuation
P/E
N/A
P/B
1.23
P/S
0.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.96
OM's EPS is up by 23% year-on-year and by 12% since the previous quarter
OM's price to book (P/B) is 72% lower than its 5-year quarterly average of 4.4 and 32% lower than its last 4 quarters average of 1.8
The equity has plunged by 69% YoY and by 30% from the previous quarter
OM's price to sales (P/S) is 96% lower than its 5-year quarterly average of 12.5 and 58% lower than its last 4 quarters average of 1.2
Outset Medical's revenue has decreased by 13% YoY
Efficiency
How efficient is Outset Medical business performance
Outset Medical's ROE has plunged by 92% YoY and by 16% from the previous quarter
The return on invested capital has increased by 37% year-on-year and by 20% since the previous quarter
OM's return on sales is up by 17% year-on-year and by 14% since the previous quarter
Outset Medical's return on assets has increased by 11% YoY and by 10% QoQ
Dividends
What is OM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OM.
Financial health
How did Outset Medical financials performed over time
The total assets is 20% greater than the total liabilities
The total liabilities has soared by 58% year-on-year
The current ratio has increased by 21% year-on-year but it has declined by 4.6% since the previous quarter
OM's debt has soared by 96% YoY
The equity has plunged by 69% YoY and by 30% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.